Regeneron Pharmaceuticals, Inc. vs Vale S.A.
Market cap comparison over time
Regeneron Pharmaceuticals, Inc.
$63.0B
Rank #231
Vale S.A.
$65.4B
Rank #226
Market Cap Over Time
Key Moments
- Regeneron Pharmaceuticals, Inc. overtook Vale S.A. by 2014
- Vale S.A. overtook Regeneron Pharmaceuticals, Inc. by 2026
Year-by-Year Comparison
| Year | Regeneron Pharmaceuticals, Inc. | Vale S.A. | Leader |
|---|---|---|---|
| 2026 | $63.0B | $65.4B | Vale S.A. |
| 2025 | $79.3B | $52.7B | Regeneron Pharmaceuticals, Inc. |
| 2024 | $72.8B | $33.1B | Regeneron Pharmaceuticals, Inc. |
| 2023 | $89.7B | $54.6B | Regeneron Pharmaceuticals, Inc. |
| 2022 | $73.7B | $53.5B | Regeneron Pharmaceuticals, Inc. |
| 2021 | $64.5B | $40.5B | Regeneron Pharmaceuticals, Inc. |
| 2020 | $49.4B | $41.1B | Regeneron Pharmaceuticals, Inc. |
| 2019 | $38.4B | $30.3B | Regeneron Pharmaceuticals, Inc. |
| 2018 | $38.2B | $30.2B | Regeneron Pharmaceuticals, Inc. |
| 2017 | $38.4B | $26.7B | Regeneron Pharmaceuticals, Inc. |
| 2016 | $37.5B | $16.0B | Regeneron Pharmaceuticals, Inc. |
| 2015 | $55.5B | $6.9B | Regeneron Pharmaceuticals, Inc. |
| 2014 | $41.9B | $16.3B | Regeneron Pharmaceuticals, Inc. |
| 2013 | $28.1B | $29.1B | Vale S.A. |
| 2012 | $17.5B | $38.0B | Vale S.A. |
| 2011 | $5.7B | $36.7B | Vale S.A. |
| 2010 | $3.4B | $55.6B | Vale S.A. |
| 2009 | $2.5B | $45.9B | Vale S.A. |
| 2008 | $1.9B | $18.7B | Vale S.A. |
| 2007 | $2.5B | $49.0B | Vale S.A. |
| 2006 | $2.1B | $22.0B | Vale S.A. |
| 2005 | $1.6B | $14.9B | Vale S.A. |
| 2004 | $941.1M | $10.2B | Vale S.A. |
| 2003 | $1.5B | $6.6B | Vale S.A. |
| 2002 | $1.9B | $3.1B | Vale S.A. |